This Article  • Full text  • PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on Web of Science (100)  • Contact me when this article is cited  Related Content  • Related article  • Similar articles in this journal  Topic Collections  • Neurogenetics  • Genetic Disorders  • Genetics, Other  • Hypertension  • Alert me on articles by topic  Social Bookmarking   What's this?

Charles DeCarli, MD; Bruce L. Miller, MD; Gary E. Swan, PhD; Terry Reed, PhD; Philip A. Wolf, MD; Dorit Carmelli, PhD

Arch Neurol. 2001;58:643-647.

Objective  To evaluate the relative risk (RR) of mild cognitive impairment (MCI) associated with cerebrovascular risk factors and cerebrovascular-related brain changes.

Design  Mild cognitive impairment was determined for the subjects of the prospective National Heart, Lung, and Blood Institute Twin Study. Quantitative measures of brain, white matter hyperintensity, cerebral infarction, apolipoprotein E genotype, and psychometric testing were obtained.

Results  Subjects with MCI were older (73.5 ± 3.0 vs 72.1 ± 2.8 years), consumed less alcohol (3.7 ± 5.8 vs 7.0 ± 10.7 drinks per week), had greater white matter hyperintensity volumes (0.56% ± 0.82% vs 0.25% ± 0.34% of cranial volume), and had an increased prevalance of apolipoprotein E4 genotype (31.4% vs 19.2%) than normal subjects. White matter hyperintensity and the presence of the apolipoprotein E4 genotype were associated with a significantly increased risk for MCI. When all subjects were included in the analysis, alcohol consumption was associated with a reduced risk for MCI (RR = 0.93, P<.05). When subjects with a history of symptomatic cerebrovascular disease were excluded from the analysis, elevated midlife diastolic blood pressure was associated with an increased risk for MCI (RR = 1.70, P<.05).

Conclusions  Elevated midlife blood pressures, and the resulting increased white matter hyperintensities, increase the risk for MCI in a group of community-dwelling older men to at least the same degree as apolipoprotein E4 genotype. Given the common occurrence of elevations in midlife blood pressure, early and effective treatment may be warranted to prevent late-life brain abnormalities and MCI. Moreover, since many individuals with MCI progress to clinical dementia, longitudinal evaluations of this cohort will be important.

From the Department of Neurology, University of Kansas, Kansas City (Dr DeCarli); Department of Neurology, University of California at San Francisco (Dr Miller); Health Sciences Division, SRI International, Menlo Park, Calif (Drs Swan and Carmelli); Department of Medical and Molecular Genetics, Indiana University, Indianapolis (Dr Reed); and Department of Neurology, Boston University, Boston, Mass (Dr Wolf). Dr DeCarli is now with the Department of Neurology, University of California at Davis.

Corresponding author and reprints: Charles DeCarli, MD, Department of Neurology, University of California at Davis, 4860 Y St, Suite 3700, Sacramento, CA 95817 (e-mail: cdecarli{at}ucdavis.edu).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

RELATED ARTICLE

Archives of Neurology Reader's Choice: Continuing Medical Education
Arch Neurol. 2001;58(4):684-685.
FULL TEXT  

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Regional pattern of white matter microstructural changes in normal aging, MCI, and AD
Lee et al.
Neurology 2009;73:1722-1728.
ABSTRACT | FULL TEXT  

Differences in Brain Volume, Hippocampal Volume, Cerebrovascular Risk Factors, and Apolipoprotein E4 Among Mild Cognitive Impairment Subtypes
He et al.
Arch Neurol 2009;66:1393-1399.
ABSTRACT | FULL TEXT  

Subclinical cerebrovascular disease in mild cognitive impairment
Luchsinger et al.
Neurology 2009;73:450-456.
ABSTRACT | FULL TEXT  

Mediterranean Diet and Mild Cognitive Impairment
Scarmeas et al.
Arch Neurol 2009;66:216-225.
ABSTRACT | FULL TEXT  

Hippocampal Volumes, Proton Magnetic Resonance Spectroscopy Metabolites, and Cerebrovascular Disease in Mild Cognitive Impairment Subtypes
Kantarci et al.
Arch Neurol 2008;65:1621-1628.
ABSTRACT | FULL TEXT  

The Apolipoprotein E {epsilon}4 Allele is not Associated With Cognitive Dysfunction in Cardiac Surgery
Silbert et al.
Ann. Thorac. Surg. 2008;86:841-847.
ABSTRACT | FULL TEXT  

Association of Blood Pressure and Genetic Background With White Matter Lesions in Patients With Mild Cognitive Impairment
Galluzzi et al.
Journals of Gerontology Series A: Biological Sciences and Medical Sciences 2008;63:510-517.
ABSTRACT | FULL TEXT  

Spatial Distribution of White-Matter Hyperintensities in Alzheimer Disease, Cerebral Amyloid Angiopathy, and Healthy Aging
Holland et al.
Stroke 2008;39:1127-1133.
ABSTRACT | FULL TEXT  

Magnetic Resonance Imaging White Matter Hyperintensities and Brain Volume in the Prediction of Mild Cognitive Impairment and Dementia
Smith et al.
Arch Neurol 2008;65:94-100.
ABSTRACT | FULL TEXT  

Prevalence of Subcortical Vascular Lesions and Association With Executive Function in Mild Cognitive Impairment Subtypes
Bombois et al.
Stroke 2007;38:2595-2597.
ABSTRACT | FULL TEXT  

Endothelial Function and White Matter Hyperintensities in Older Adults With Cardiovascular Disease
Hoth et al.
Stroke 2007;38:308-312.
ABSTRACT | FULL TEXT  

Extent and distribution of white matter hyperintensities in normal aging, MCI, and AD
Yoshita et al.
Neurology 2006;67:2192-2198.
ABSTRACT | FULL TEXT  

Mild cognitive impairment (MCI) in medical practice: a critical review of the concept and new diagnostic procedure. Report of the MCI Working Group of the European Consortium on Alzheimer's Disease
Portet et al.
J. Neurol. Neurosurg. Psychiatry 2006;77:714-718.
ABSTRACT | FULL TEXT  

Clinical trials in mild cognitive impairment: lessons for the future
Jelic et al.
J. Neurol. Neurosurg. Psychiatry 2006;77:429-438.
ABSTRACT | FULL TEXT  

Association of White Matter Hyperintensity Volume With Decreased Cognitive Functioning: The Framingham Heart Study
Au et al.
Arch Neurol 2006;63:246-250.
ABSTRACT | FULL TEXT  

Decline in intelligence is associated with progression in white matter hyperintensity volume
Garde et al.
J. Neurol. Neurosurg. Psychiatry 2005;76:1289-1291.
ABSTRACT | FULL TEXT  

Anatomical Mapping of White Matter Hyperintensities (WMH): Exploring the Relationships Between Periventricular WMH, Deep WMH, and Total WMH Burden
DeCarli et al.
Stroke 2005;36:50-55.
ABSTRACT | FULL TEXT  

MCI conversion to dementia and the APOE genotype: A prediction study with FDG-PET
Mosconi et al.
Neurology 2004;63:2332-2340.
ABSTRACT | FULL TEXT  

Vascular risk factors, incidence of MCI, and rates of progression to dementia
Solfrizzi et al.
Neurology 2004;63:1882-1891.
ABSTRACT | FULL TEXT  

Memory impairment, but not cerebrovascular disease, predicts progression of MCI to dementia
DeCarli et al.
Neurology 2004;63:220-227.
ABSTRACT | FULL TEXT  

Medial temporal lobe atrophy on MRI predicts dementia in patients with mild cognitive impairment
Korf et al.
Neurology 2004;63:94-100.
ABSTRACT | FULL TEXT  

Cerebrospinal Fluid Tau Protein and Periventricular White Matter Lesions in Patients With Mild Cognitive Impairment: Implications for 2 Major Pathways
Maruyama et al.
Arch Neurol 2004;61:716-720.
ABSTRACT | FULL TEXT  

Framingham Stroke Risk Profile and Lowered Cognitive Performance
Elias et al.
Stroke 2004;35:404-409.
ABSTRACT | FULL TEXT  

Neuroimaging tools to rate regional atrophy, subcortical cerebrovascular disease, and regional cerebral blood flow and metabolism: consensus paper of the EADC
Frisoni et al.
J. Neurol. Neurosurg. Psychiatry 2003;74:1371-1381.
ABSTRACT | FULL TEXT  

Blood Pressure and Cognitive Impairment in India and the United States: A Cross-National Epidemiological Study
Pandav et al.
Arch Neurol 2003;60:1123-1128.
ABSTRACT | FULL TEXT  

Cigarette Smoking and Alcohol Consumption in Relation to Cognitive Performance in Middle Age
Kalmijn et al.
Am J Epidemiol 2002;156:936-944.
ABSTRACT | FULL TEXT  

Cognitive decline in AD and mild cognitive impairment is associated with global brain damage
van der Flier et al.
Neurology 2002;59:874-879.
ABSTRACT | FULL TEXT  

Alzheimer Disease as a Vascular Disorder: Nosological Evidence
de la Torre
Stroke 2002;33:1152-1162.
ABSTRACT | FULL TEXT